Results 331 to 340 of about 3,480,656 (399)

MEPED as salvage therapy for relapsed/refractory Hodgkin's lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck. [PDF]

Front Pharmacol
Harrer DC, Lüke F, Pukrop T, Ghibelli L, Reichle A, Heudobler D.   +5 more
europepmc   +1 more source

Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines. [PDF]

Front Immunol
Hodgson D, Liu Y, Carolan L, Mahanty S, Subbarao K, Sullivan SG, Fox A, Kucharski A.   +7 more
europepmc   +1 more source

Oncologic and fertility outcome in patients with advanced stage ovarian immature teratomas. [PDF]

Gynecol Oncol Rep
Giuseppe M, Serena N, Filippo T, Daniela G, Elena P, Martina B, Pecis Cavagna G, Daniele L, Marta J, Alessandra C, Tommaso B, Tommaso G, Maria Cristina B, Robert F.   +13 more
europepmc   +1 more source

Finite Element Simulation of Hot Rolling for Large-Scale AISI 430 Ferritic Stainless-Steel Slabs Using Industrial Rolling Schedules-Part 2: Simulation of the Roughing Stage and Comparison with Experimental Results. [PDF]

Materials (Basel)
Ojeda-López A, Botana-Galvín M, Almagro Bello JF, González-Rovira L, Botana FJ.   +4 more
europepmc   +1 more source

Global distribution and characteristics of pneumococcal serotypes in adults. [PDF]

Hum Vaccin Immunother
Maeda H, Morimoto K.
europepmc   +1 more source

Determinants of immunisation in children with sickle cell disease in Libreville. [PDF]

J Public Health Afr
Ngoungou EB, Bisvigou UJ, Engohang-Ndong J, Anguezomo V, Sydney MN, Ibinga E.   +5 more
europepmc   +1 more source

Immunogenicity of co-administered vaccine antigens with whole-cell or acellular pertussis vaccines in infancy: a randomised controlled trial

Pérez Chacón G, McAlister S, Totterdell J, Estcourt MJ, Marsh JA, Jones M, Perrett KP, Campbell DE, Wood N, Gold M, Waddington CS, O’Sullivan M, Curtis N, Wadia U, McIntyre PB, Holt PG, Snelling T, Richmond PC.   +17 more
europepmc   +1 more source